Pre-implantation Genetic Screening, now commonly called PGT-A, examines embryos for the correct number of chromosomes. Embryos with abnormal chromosome numbers are a leading cause of failed implantation and miscarriage, particularly as a woman gets older.
Women of advanced maternal age.
Couples with recurrent miscarriage.
Repeated implantation failure after good-quality embryo transfers.
Couples who want to reduce the chance of chromosomal problems.
Your specialist will discuss whether screening is right for you.
During IVF, a small sample of cells is taken from each blastocyst and tested.
Embryos are usually frozen while results are awaited.
A normal embryo is transferred in a later cycle.
Research shows that PGT-A may shorten time to pregnancy and reduce miscarriage in some groups, but it does not increase the number of embryos and benefits are not equal for every patient. Some embryos labelled abnormal may be mosaic. Your specialist will discuss whether screening is right for you.
Curis Global arranges consultation with fertility specialists, explains the cost and the process and handles your travel and stay.
No. PGS looks at chromosome numbers generally, while PGD tests for a known inherited condition.
No. It improves embryo selection, but pregnancy is never guaranteed.